Expression of concern
Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial
Paper Information
Record ID:
24486
Author(s):
Journal:
Publication Date:
April 01, 2016
Retraction Date:
October 19, 2020
(5.1 years years ago)
Subjects:
Institutions:
- Cardiothoracic Department, AHEPA University Hospital, S. Kyriakidi 1, 546 36, Thessaloniki, Greece
- The John Radcliffe Hospital, Oxford University Hospitals, Headington, Oxford, UK
- Experimental Therapeutics, University of Oxford, Oxford, UK
- Department of Nuclear Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
- First Cardiology Department, AHEPA University Hospital, Thessaloniki, Greece
- School of Biosciences, Cardiff University, Wales, UK
Countries:
Article Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1007/s12265-020-10076-7Citations (15)
15
Total Citations7
Post-Retraction(46.7%)
7
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
4
After 2+ years
1515
Days since retraction (latest)
Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies
Xingpeng Di, Ya Li, Jingwen Wei et al. (5 authors)
Advanced Science
Open Access
Published: Dec 2024
7 citations
7 citations
1515 days after retraction
20 years of treating ischemic cardiomyopathy with mesenchymal stromal cells: a meta-analysis and systematic review
Burakhan Seyihoglu, Inci Orhan, Nil Okudur et al. (7 authors)
Cytotherapy
Published: Jul 2024
2 citations
2 citations
1359 days after retraction
Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine
Ali Fatehi Hassanabad, Anna N. Zarzycki, Paul W.M. Fedak
Cardiovascular Pathology
Open Access
Published: Mar 2024
6 citations
6 citations
1247 days after retraction
Mesenchymal stromal cells and pleiotropic therapeutic advantages in COVID-19 management
Vimal Kishor Singh, Uttkarsh Kumar Sharma Vaksh, Pallavi Sharma
Elsevier eBooks
Published: Jan 2024
1169 days after retraction
Mesenchymal stem cells and COVID-19: What they do and what they can do
Ejlal Abu‐El‐Rub, Ramada R. Khasawneh, Fatimah Almahasneh et al. (7 authors)
World Journal of Stem Cells
Open Access
Published: Sep 2021
8 citations
8 citations
334 days after retraction
Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases
Fernanda Gubert, Jaqueline da Silva, Juliana Ferreira Vasques et al. (8 authors)
International Journal of Molecular Sciences
Open Access
Published: Jul 2021
33 citations
33 citations
266 days after retraction
The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System
Georgina M. Ellison, Liam Colley, Katie A. O’Brien et al. (6 authors)
Frontiers in Cardiovascular Medicine
Open Access
Published: Dec 2020
35 citations
35 citations
51 days after retraction
Editorial Expression of Concern: Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial
Kyriakos Anastasiadis, Polychronis Antonitsis, Stephen Westaby et al. (8 authors)
Journal of Cardiovascular Translational Research
Open Access
Published: Oct 2020
1 citation
1 citation
Same day as retraction
Can we remove scar and fibrosis from adult human myocardium?
Ali Vazir, Kim Fox, Joseph Westaby et al. (5 authors)
European Heart Journal
Open Access
Published: Sep 2018
35 citations
35 citations
776 days before retraction
Stem cells in heart failure some considerations
Federico Benetti
Journal of Stem Cell Therapy and Transplantation
Open Access
Published: Jan 2018
998 days before retraction
Recent Progress in Stem Cell Modification for Cardiac Regeneration
Heiko Lemcke, Natalia Voronina, Gustav Steinhoff et al. (4 authors)
Stem Cells International
Open Access
Published: Jan 2018
79 citations
79 citations
1022 days before retraction
Combined Bone Marrow Stem Cell Therapy and Coronary Artery Bypass Grafting for Ischemic Heart Diseases
K.S. Ayyat
Journal of Cardiology & Cardiovascular Therapy
Open Access
Published: Mar 2017
1302 days before retraction
Cell therapy for heart disease after 15 years: Unmet expectations
Patrizia Nigro, Beatrice Bassetti, Laura Cavallotti et al. (6 authors)
Pharmacological Research
Published: Feb 2017
65 citations
65 citations
1335 days before retraction
Mesenchymal stromal cell therapy to promote cardiac tissue regeneration and repair
Agata Bartczak, Ian D. McGilvray, Armand Keating
Current Opinion in Organ Transplantation
Published: Dec 2016
18 citations
18 citations
1398 days before retraction
Change of heart: Christiaan Barnard and the first human heart transplant
Helen Cowan
British Journal of Cardiac Nursing
Published: Dec 2016
1417 days before retraction
Quick Stats
Total Citations:
15
Years Since Retraction:
5.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025